Mirion Technologies (NYSE:MIR) Receives New Price Target of $9.00 from Goldman Sachs Group
Mirion Technologies (NYSE: MIR – Get a Note) had its price target reduced by the Goldman Sachs Group from $12.00 to $9.00 in a research note released to investors on Thursday, Stock Target Advisor reports. The brokerage currently has a buy rating on the stock.
Separately, CJS Securities began covering Mirion Technologies in a research note on Thursday, March 24. They set an outperform rating and a price target of $13.00 for the stock.
Shares of MIR opened at $6.49 on Thursday. The company’s 50-day moving average is $7.49 and its two-hundred-day moving average is $8.45. Mirion Technologies has a 52 week low of $5.66 and a 52 week high of $11.95. The company has a quick ratio of 1.47, a current ratio of 2.05 and a debt ratio of 0.46.
Mirion Technologies (NYSE:MIR – Get Rating) last announced its results on Wednesday, May 4. The company reported earnings per share (EPS) of $0.10 for the quarter, beating consensus analyst estimates of $0.09 by $0.01. Mirion Technologies posted a negative return on equity of 11.44% and a negative net margin of 32.49%.
A number of hedge funds and other institutional investors have recently changed their holdings in the company. Mirabella Financial Services LLP increased its position in Mirion Technologies by 12.9% in the first quarter. Mirabella Financial Services LLP now owns 45,987 shares of the company worth $371,000 after purchasing an additional 5,267 shares during the period. Royal Bank of Canada acquired a new position in shares of Mirion Technologies during the first quarter at a value of $63,000. Gamco Investors Inc. ET AL increased its equity stake in Mirion Technologies by 6.1% during the first quarter. Gamco Investors Inc. ET AL now owns 166,846 shares of the company valued at $1,346,000 after purchasing an additional 9,646 shares during the period. Sciencast Management LP acquired a new position in shares of Mirion Technologies during the first quarter at a value of $78,000. Finally, Prelude Capital Management LLC acquired a new position in shares of Mirion Technologies during the first quarter at a value of $85,000. 78.79% of the shares are currently held by hedge funds and other institutional investors.
Mirion Technologies Company Profile (Get a rating)
Mirion Technologies, Inc provides radiation detection, measurement, analysis and monitoring products and services in the United States, Canada, United Kingdom, France, Germany, Finland, China, Belgium , the Netherlands, Estonia and Japan. It operates through two segments, medical and industrial. The medical segment offers quality assurance and dosimetry solutions in radiation oncology; patient safety solutions for diagnostic imaging and radiation therapy centers; radiotherapy quality assurance solutions for calibration and accuracy verification of imaging and treatment; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture and rehabilitation products.
Receive daily news and reviews for Mirion Technologies – Enter your email address below to receive a concise daily summary of the latest news and analyst assessments for Mirion Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.